Key facts
- This page summarizes Sandler Carl Forest's Form 4 filing for Enochian Biosciences Inc (RENB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2022, 09:16.
Sandler Carl Forest - 15 Apr 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)
- Reporting relationship
- Other*
- Issuer ticker
- RENB
- Reported as of
- 15 Apr 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2022, 09:16:17 UTC
- Prior SEC filing
- 24 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- Sandler Carl Forest
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sandler Carl Forest filed Form 4 for Enochian Biosciences Inc (RENB) on 03 Aug 2022.
Change
- Previous filing in this sequence was filed on 24 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RENB
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -3,969,090
- Change %
- -53%
- Price
- $0.000000
- Shares after
- 3,456,831
- Date
- 15 Apr 2022
- Ownership
- N/A
- Footnotes
- F1
RENB
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +992,273
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 4,449,104
- Date
- 15 Apr 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Sandler Carl Forest is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
By Weird Science, LLC
SEC remarks
The Reporting Person is no longer a Board Director of Enochian or a Manager of Weird Science. He is no longer a beneficial owner of any Enochian shares through Weird Science. He previously reported beneficial ownership of 4,961,363 shares legally owned by Weird Science. Weird Science has distributed these shares to its stockholders, 992,273 to the Reporting Person and 3,969,090 to others.